ENTITY
Kalbe Farma

Kalbe Farma (KLBF IJ)

144
Analysis
Health CareIndonesia
PT Kalbe Farma Tbk produces and develops pharmaceutical products for human and animal healthcare. Through its subsidiaries, the Company also operates in the pharmaceutical, health food, and packaging industries.
more
Refresh
bullishKalbe Farma
15 May 2024 18:59Broker

Kalbe Farma - Resilient Growth Outlook at Reasonable Valuation

Unbranded Generic and distribution to drive FY24F top line, while CH and Nutrition revenue normalized. We raised FY24-25F NP by 4.5-2.9%

Logo
141 Views
Share
bullishKalbe Farma
14 May 2024 19:55Broker

Kalbe Farma (KLBF.IJ) - Resilient Growth Outlook at Reasonable Valuation

Unbranded Generic and distribution to drive FY24F top line, while CH and Nutrition revenue normalized We raised FY24-25F NP by 4.5-2.9%, driven by...

Logo
165 Views
Share
bearishKalbe Farma
28 Feb 2024 20:03Broker

Kalbe Farma - Retaining Our Conservative FY24 View

Post FY23 earnings (broadly in-line vs our est.), KLBF guides for further improvements in FY24F revenues/ EPS growth at 6-7% and 13-15% yoy.

Logo
205 Views
Share
bearishKalbe Farma
16 Nov 2023 20:41Broker

Kalbe Farma (KLBF IJ) - Persisting Headwind in FY24 from Shifting Industry Trend

Against this headwind, we project a lower FY24F earnings growth of 2.9% yoy (21-27% cut in FY23-25F est.) and cut our rating to HOLD with a lower...

Logo
360 Views
Share
bullishKalbe Farma
09 Oct 2023 11:34Broker

Kalbe Farma (KLBF IJ) - Better Outlook Amid Potential 4Q23 Improved Margin

KLBF foresees better margins in 4Q23 and 2024, supported by the nutritional division (4Q23) and a favorable product mix (2024).

Logo
245 Views
Share
x